综合蛋白质组学突出了蛋白质组作为胚胎瘤的治疗脆弱性,具有多层的粉丝圈
Matthias Dottermusch1,2, Ali Biabani3, Tasja Lempertz1
1Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Neuro-oncology
|December 30, 2023
概括
带有多层红的胚胎瘤 (ETMR) 是一种罕见的脑瘤,预后不佳. 蛋白质组分析显示,ETMR细胞依赖蛋白质组机制,使蛋白质组抑制成为一个有前途的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 蛋白质组学是指蛋白质组学.
- 癌症生物学 癌症生物学
背景情况:
- 带有多层红的胚胎瘤 (ETMR) 是罕见的,侵袭性的儿科脑瘤.
- 目前对ETMR生物学的理解是有限的,很少有聚焦于核酸的分子研究.
- 由于ETMR的预后不佳,迫切需要新的治疗策略.
研究的目的:
- 研究ETMR的蛋白质组,以发现新的治疗点.
- 将蛋白质组数据与其他分子数据整合起来,以全面了解ETMR.
- 探索ETMR中蛋白酶体抑制的治疗潜力.
主要方法:
- 使用质谱法从16个ETMR样本和BT183细胞系中获取蛋白质组数据.
- 蛋白质组数据与DNA甲基化,转录组和其他胚胎/儿科脑瘤蛋白质组数据相结合.
- 在体外测试中使用BT183细胞系进行了测试,以测试蛋白质酶抑制的有效性.
主要成果:
- 基于蛋白质组的聚类与具有独特分子特征的ETMR组织形态相关 (神经元与干细胞/染色体组织).
- ETMR和BT183细胞表现出丰富的蛋白质酶调节蛋白,这表明蛋白质酶对蛋白质稳定机制的依赖.
- 实验室研究表明ETMR瘤细胞对蛋白酶体抑制剂Marizomib的高脆弱性.
结论:
- ETMR 组织形态学体现在其蛋白质组签名中.
- 在ETMR中丰富的蛋白质酶调节蛋白表明对这种途径的依赖.
- 蛋白质酶抑制是ETMR的一个有希望的治疗途径,在体外验证.
相关概念视频
Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
The Proteasome
846
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
846


